Moreover, SARS‐CoV‐2 patients display tau hyperphosphorylation implicated in AD (Reiken et al., 2022), and an increased risk of AD following SARS‐CoV‐2 infection has been suggested (Wang et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.